Annexin A2 Promotes the Migration and Invasion of Human Hepatocellular Carcinoma Cells In Vitro by Regulating the Shedding of CD147-Harboring Microvesicles from Tumor Cells

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Zhang, Wei ^a,b   Zhao, Pu ^c,d   Xu, Xiu Li ^a   Cai, Lei ^a   Song, Zhen Shun ^a   Cao, Da Yong ^a   Tao, Kai Shan ^a   Zhou, Wen Ping ^b   Chen, Zhi Nan ^d   Dou, Ke Feng ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b GENERAL HOSPITAL OF NORTHERN THEATER COMMAND   (China)

^c NORTHEASTERN UNIVERSITY   (China)

^d FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD147 ANTIGEN; GELATINASE A; LIPOCORTIN 2; SMALL INTERFERING RNA;

ARTICLE; CANCER INHIBITION; CARCINOMA CELL; CELL INVASION; CELL MEMBRANE; CELL MIGRATION; CELL VACUOLE; COCULTURE; CONTROLLED STUDY; DOWN REGULATION; ENZYME SYNTHESIS; FIBROBLAST; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IN VITRO STUDY; LIVER CELL CARCINOMA; MEMBRANE STRUCTURE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN TRANSPORT; REGULATORY MECHANISM; STROMA;

ANNEXIN A2; ANTIGENS, CD147; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL MEMBRANE; CELL MOVEMENT; COCULTURE TECHNIQUES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIVER NEOPLASMS; MICROVESSELS; NEOPLASM INVASIVENESS; NEOVASCULARIZATION, PATHOLOGIC; PROTEIN BINDING; PROTEIN TRANSPORT; RNA INTERFERENCE;

EID: 84881520703     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0067268     Document Type: Article

References (38)

1. Gerke V, Moss SE, (2002) Annexins: from structure to function. Physiol Rev 82: 331-371.
2. Singh P, (2007) Role of Annexin-II in GI cancers: interaction with gastrins/progastrins. Cancer Lett 252: 19-35.
3. Mussunoor S, Murray GI, (2008) The role of annexins in tumour development and progression. J Pathol 216: 131-140.
4. Gerke V, Creutz CE, Moss SE, (2005) Annexins: linking Ca2+ signalling to membrane dynamics. Nat Rev Mol Cell Biol 6: 449-461.
5. Lorusso A, Covino C, Priori G, Bachi A, Meldolesi J, et al. (2006) Annexin2 coating the surface of enlargeosomes is needed for their regulated exocytosis. Embo J 25: 5443-5456.
6. Sharma MC, Sharma M, (2007) The role of annexin II in angiogenesis and tumor progression: a potential therapeutic target. Curr Pharm Des 13: 3568-3575.
7. Keutzer JC, Hirschhorn RR, (1990) The growth-regulated gene 1B6 is identified as the heavy chain of calpactin I. Exp Cell Res 188: 153-159.
8. Hajjar KA, Guevara CA, Lev E, Dowling K, Chacko J, (1996) Interaction of the fibrinolytic receptor, annexin II, with the endothelial cell surface. Essential role of endonexin repeat 2. J Biol Chem 271: 21652-21659.
9. Brichory FM, Misek DE, Yim AM, Krause MC, Giordano TJ, et al. (2001) An immune response manifested by the common occurrence of annexins I and II autoantibodies and high circulating levels of IL-6 in lung cancer. Proc Natl Acad Sci U S A 98: 9824-9829.
10. Masaki T, Tokuda M, Fujimura T, Ohnishi M, Tai Y, et al. (1994) Involvement of annexin I and annexin II in hepatocyte proliferation: can annexins I and II be markers for proliferative hepatocytes? Hepatology 20: 425-435.
11. Sharma MR, Rothman V, Tuszynski GP, Sharma MC, (2006) Antibody-directed targeting of angiostatin's receptor annexin II inhibits Lewis Lung Carcinoma tumor growth via blocking of plasminogen activation: possible biochemical mechanism of angiostatin's action. Exp Mol Pathol 81: 136-145.
12. Sharma MR, Koltowski L, Ownbey RT, Tuszynski GP, Sharma MC, (2006) Angiogenesis-associated protein annexin II in breast cancer: selective expression in invasive breast cancer and contribution to tumor invasion and progression. Exp Mol Pathol 81: 146-156.
13. Zimmermann U, Woenckhaus C, Pietschmann S, Junker H, Maile S, et al. (2004) Expression of annexin II in conventional renal cell carcinoma is correlated with Fuhrman grade and clinical outcome. Virchows Arch 445: 368-374.
14. Wu W, Tang X, Hu W, Lotan R, Hong WK, et al. (2002) Identification and validation of metastasis-associated proteins in head and neck cancer cell lines by two-dimensional electrophoresis and mass spectrometry. Clin Exp Metastasis 19: 319-326.
15. Pena-Alonso E, Rodrigo JP, Parra IC, Pedrero JM, Meana MV, et al. (2008) Annexin A2 localizes to the basal epithelial layer and is down-regulated in dysplasia and head and neck squamous cell carcinoma. Cancer Lett 263: 89-98.
16. Zheng L, Foley K, Huang L, Leubner A, Mo G, et al. (2011) Tyrosine 23 phosphorylation-dependent cell-surface localization of annexin A2 is required for invasion and metastases of pancreatic cancer. PLoS One 6: e19390.
17. Liu JW, Shen JJ, Tanzillo-Swarts A, Bhatia B, Maldonado CM, et al. (2003) Annexin II expression is reduced or lost in prostate cancer cells and its re-expression inhibits prostate cancer cell migration. Oncogene 22: 1475-1485.
18. Hastie C, Masters JR, Moss SE, Naaby-Hansen S, (2008) Interferon-gamma reduces cell surface expression of annexin 2 and suppresses the invasive capacity of prostate cancer cells. J Biol Chem 283: 12595-12603.
19. Mohammad HS, Kurokohchi K, Yoneyama H, Tokuda M, Morishita A, et al. (2008) Annexin A2 expression and phosphorylation are up-regulated in hepatocellular carcinoma. Int J Oncol 33: 1157-1163.
20. Brownstein C, Deora AB, Jacovina AT, Weintraub R, Gertler M, et al. (2004) Annexin II mediates plasminogen-dependent matrix invasion by human monocytes: enhanced expression by macrophages. Blood 103: 317-324.
21. Hwang J, Hodis HN, Hsiai TK, Asatryan L, Sevanian A, (2006) Role of annexin II in estrogen-induced macrophage matrix metalloproteinase-9 activity: the modulating effect of statins. Atherosclerosis 189: 76-82.
22. Biswas C, (1982) Tumor cell stimulation of collagenase production by fibroblasts. Biochem Biophys Res Commun 109: 1026-1034.
23. Chen Y, Gou X, Ke X, Cui H, Chen Z, (2012) Human tumor cells induce angiogenesis through positive feedback between CD147 and insulin-like growth factor-I. PLoS One 7: e40965.
24. Yan L, Zucker S, Toole BP, (2005) Roles of the multifunctional glycoprotein, emmprin (basigin; CD147), in tumour progression. Thromb Haemost 93: 199-204.
25. Biswas C, Zhang Y, DeCastro R, Guo H, Nakamura T, et al. (1995) The human tumor cell-derived collagenase stimulatory factor (renamed EMMPRIN) is a member of the immunoglobulin superfamily. Cancer Res 55: 434-439.
26. Tang Y, Kesavan P, Nakada MT, Yan L, (2004) Tumor-stroma interaction: positive feedback regulation of extracellular matrix metalloproteinase inducer (EMMPRIN) expression and matrix metalloproteinase-dependent generation of soluble EMMPRIN. Mol Cancer Res 2: 73-80.
27. Sun J, Hemler ME, (2001) Regulation of MMP-1 and MMP-2 production through CD147/extracellular matrix metalloproteinase inducer interactions. Cancer Res 61: 2276-2281.
28. Egawa N, Koshikawa N, Tomari T, Nabeshima K, Isobe T, et al. (2006) Membrane type 1 matrix metalloproteinase (MT1-MMP/MMP-14) cleaves and releases a 22-kDa extracellular matrix metalloproteinase inducer (EMMPRIN) fragment from tumor cells. J Biol Chem 281: 37576-37585.
29. Sidhu SS, Mengistab AT, Tauscher AN, LaVail J, Basbaum C, (2004) The microvesicle as a vehicle for EMMPRIN in tumor-stromal interactions. Oncogene 23: 956-963.
30. Millimaggi D, Mari M, D'Ascenzo S, Carosa E, Jannini EA, et al. (2007) Tumor vesicle-associated CD147 modulates the angiogenic capability of endothelial cells. Neoplasia 9: 349-357.
31. Xu J, Xu HY, Zhang Q, Song F, Jiang JL, et al. (2007) HAb18G/CD147 functions in invasion and metastasis of hepatocellular carcinoma. Mol Cancer Res 5: 605-614.
32. Tang J, Wu YM, Zhao P, Yang XM, Jiang JL, et al. (2008) Overexpression of HAb18G/CD147 promotes invasion and metastasis via alpha3beta1 integrin mediated FAK-paxillin and FAK-PI3K-Ca2+ pathways. Cell Mol Life Sci 65: 2933-2942.
33. Zhao P, Zhang W, Tang J, Ma XK, Dai JY, et al. (2010) Annexin II promotes invasion and migration of human hepatocellular carcinoma cells in vitro via its interaction with HAb18G/CD147. Cancer Sci 101: 387-395.
34. Zhao P, Zhang W, Wang SJ, Yu XL, Tang J, et al. (2011) HAb18G/CD147 promotes cell motility by regulating annexin II-activated RhoA and Rac1 signaling pathways in hepatocellular carcinoma cells. Hepatology 54: 2012-2024.
35. Frohlich M, Motte P, Galvin K, Takahashi H, Wands J, et al. (1990) Enhanced expression of the protein kinase substrate p36 in human hepatocellular carcinoma. Mol Cell Biol 10: 3216-3223.
36. Heijnen HF, Schiel AE, Fijnheer R, Geuze HJ, Sixma JJ, (1999) Activated platelets release two types of membrane vesicles: microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha-granules. Blood 94: 3791-3799.
37. Ginestra A, La Placa MD, Saladino F, Cassara D, Nagase H, et al. (1998) The amount and proteolytic content of vesicles shed by human cancer cell lines correlates with their in vitro invasiveness. Anticancer Res 18: 3433-3437.
38. Taraboletti G, D'Ascenzo S, Borsotti P, Giavazzi R, Pavan A, et al. (2002) Shedding of the matrix metalloproteinases MMP-2, MMP-9, and MT1-MMP as membrane vesicle-associated components by endothelial cells. Am J Pathol 160: 673-680.